Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.455
-0.055 (-1.22%)
Jul 1, 2025, 10:30 AM - Market open
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $201.79 million as of July 1, 2025. Its market cap has decreased by -61.74% in one year.
Market Cap
201.79M
Enterprise Value
144.58M
1-Year Change
-61.74%
Ranking
Category
Stock Price
$4.46
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $201.79M, a decrease of -74.67%. That is a compound annual growth rate of -18.34%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |